Open AccessCurrent state of antigen-specific immunotherapy for type 1 diabetes
Author(s) -
Frederik Flindt Kreiner,
Bernt Johan von Scholten,
Ken Coppieters,
Matthias von Herrath
Publication year - 2021
Publication title -
current opinion in endocrinology, diabetes and obesity./current opinion in endocrinology, diabetes and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.199
H-Index - 67
eISSN - 1752-2978
pISSN - 1752-296X
DOI - 10.1097/med.0000000000000647
Subject(s) - immunotherapy , current (fluid) , medicine , immunology , type 1 diabetes , state (computer science) , antigen , computer science , diabetes mellitus , endocrinology , immune system , engineering , electrical engineering , algorithm
Update on antigen-specific immunotherapy (ASIT) in type 1 diabetes (T1D) with focus on deoxyribonucleic acid (DNA)-induced immunization and the current obstacles to further research and clinical realization.